FDA speeds review of Iowa City firm’s AI blindness detection system
Iowa City-based IDx, an artificial intelligence diagnostics company working on a system to detect a leading cause of blindness, has won U.S. Food and Drug Administration approval for expedited review. IDx-DR uses AI to check for diabetic retinopathy. The FDA ruled the system is a “breakthrough device” that qualifies for…